Catalio Capital Management, LP Spring Works Therapeutics, Inc. Transaction History
Catalio Capital Management, LP
- $411 Billion
- Q1 2025
A detailed history of Catalio Capital Management, LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Catalio Capital Management, LP holds 758,533 shares of SWTX stock, worth $35.6 Million. This represents 8.14% of its overall portfolio holdings.
Number of Shares
758,533
Previous 764,668
0.8%
Holding current value
$35.6 Million
Previous $27.6 Billion
21.16%
% of portfolio
8.14%
Previous 6.04%
Shares
2 transactions
Others Institutions Holding SWTX
# of Institutions
337Shares Held
63.7MCall Options Held
5.81MPut Options Held
2.55M-
Vanguard Group Inc Valley Forge, PA7.08MShares$333 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$264 Million0.0% of portfolio
-
State Street Corp Boston, MA2.92MShares$137 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.58MShares$121 Million0.01% of portfolio
-
Woodline Partners LP San Francisco, CA2.14MShares$101 Million0.66% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.93B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...